Early Mortality Risk Score: Identification of Poor Outcomes Following Upfront Surgery for Resectable Pancreatic Cancer

Abstract

Background Identifying pancreatic cancer patients at high risk of early mortality following pancreaticoduodenectomy (PD) is important for treatment decisions in a multidisciplinary setting. This study examines the preoperative predictors of early mortality following PD and combines these variables into an early mortality risk score (EMRS). Methods Medical records of patients who underwent PD for pancreatic adenocarcinoma at the Johns Hopkins Hospital between 30 August 1993 and 28 February 2005 were reviewed. Cox proportional hazards analysis was performed to identify predictors of early mortality, defined as death at 9 and 12 months. EMRS was constructed from univariate associated risk factors (age >75 years, tumor size ≥3cm, poor differentiation, co-morbid diseases) with each factor assigned 1 point (range of 0–4). EMRS was evaluated as an independent predictor of death at 9 and 12 months. Results On univariate analysis, risk factors for death at 9 months included age ≥75 years (RR, 1.6; p=.009), comorbid disease (RR, 1.5; p=0.020), tumor ≥3 cm (RR, 1.4; P=0.050), and poor differentiation (RR, 2.1; P<0.001). EMRS was associated with early mortality among those who did (p=0.038) and did not receive adjuvant treatment (p<0.001). A modified EMRS without tumor differentiation was also associated with early mortality (p<0.001). Results persisted when reanalyzed using death at 12 months. Conclusions EMRS may identify patients at risk of early mortality following PD who may be candidates for alternatively sequenced treatment protocols. Prospective validation of this EMRS is needed.

Neoadjuvant chemotherapy in borderline resectable pancreatic cancer: A case report

“…Secondly, besides overall health status, the presence of significant comorbidities and nutritional deficiency (18), understanding tumor biology may assist clinicians in selecting patients for surgery. No validated prognostic biomarkers predict recurrence following resection.…”

Whipple procedure: patient selection and special considerations

“…4 Significant predictors of 30day mortality included COPD, hypertension, neoadjuvant radiation therapy, elevated serum creatinine, and hypoalbuminemia. Japanese studies have demonstrated that risk factors for inhospital mortality were age, respiratory distress, activities of daily living within 30 days before surgery, angina, weight loss of more than 10%, American Society of Anesthesiologist class greater than 3, Brinkman index of more than 400, body mass index (BMI) of more than 25 kg/m 2 , white blood cell count of more than 11,000 cells/µL, platelet count of less than 120,000/µL, prothrombin time/international normal ized ratio of more than 1.1, activated partial thromboplastin time of more than 40 seconds, and serum creatinine levels of more than 3 mg/dL. 4 Male sex, emergency surgery, COPD, bleeding disorders, and blood urea nitrogen less than 8 mg/dL were independent variables in the 30day mortality group.…”

“…The postoperative medical complication rate is 4%-19%. 2 Overall, the mortality risk due to pancreatic surgery is less than 5%. 3 …”

Implementation and Evaluation of a Clinical Pathway for Pancreaticoduodenectomy Procedures: a Prospective Cohort Study

“…1,2 Centralization of pancreas surgery and advances in surgical techniques resulted in more patients being operated for advanced-staged tumours. 3,4 Patients with more comorbidity receiving pre-operative chemotherapy and/or vascular reconstructions in advanced disease, need more complex perioperative care.…”